# Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

> **NCT00409643** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 1259 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan+amlodipine combination
- **DRUG:** valsartan
- **DRUG:** amlodipine

## Key facts

- **NCT ID:** NCT00409643
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 1259 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00409643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00409643, "Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00409643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*